- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00756353
Survey of Buprenorphine Use Among "Out of Care" Population in France (P04933)(COMPLETED)
March 16, 2023 updated by: Indivior Inc.
Out of Care Patient Survey
This study was a survey of drug users who obtain buprenorphine from the black market and have used buprenorphine during the last month.
Subjects were surveyed at various locations (streets, railway stations, etc.) with a few simple questions in order to describe the use of buprenorphine in this "out of care" population.
Study Overview
Status
Completed
Conditions
Detailed Description
Participants were found from various places and using a "snow ball" technique.
Study Type
Observational
Enrollment (Actual)
600
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The population in this survey includes drug users who are in the "out of care" population, found in various places (streets, railway stations) and via the "snow ball" technique.
Description
Inclusion Criteria:
- Drug users who have obtained buprenorphine only on the black market or both on black market and in pharmacy.
Exclusion Criteria:
- Patients who have obtained buprenorphine only from the pharmacy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Wave 1
|
Wave 2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The objective of this survey is to describe quantitatively and qualitatively, the use of buprenorphine in the population who obtain buprenorphine only on black market or both on black market and in pharmacy.
Time Frame: Not Applicable, cross-sectional description.
|
Not Applicable, cross-sectional description.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
This survey will provide data on patients in regards to their own experience in drug addiction.
Time Frame: Not Applicable, cross-sectional description.
|
Not Applicable, cross-sectional description.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2006
Primary Completion (Actual)
December 1, 2006
Study Completion (Actual)
December 1, 2006
Study Registration Dates
First Submitted
September 19, 2008
First Submitted That Met QC Criteria
September 19, 2008
First Posted (Estimate)
September 22, 2008
Study Record Updates
Last Update Posted (Actual)
March 20, 2023
Last Update Submitted That Met QC Criteria
March 16, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P04933
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Addiction
-
Virginia Commonwealth UniversityCompletedSubstance Use Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Drug Dependence | Drug Use Disorders | Substance AddictionUnited States
-
Yale UniversityHealth Resources and Services Administration (HRSA); The New York Academy of... and other collaboratorsCompletedHIV | Substance Abuse | Drug Abuse | Substance-related Disorders | Drug Addiction | Opiate Addiction | Drug Use Disorder | Buprenorphine | Drug Dependence | Drug Use DisordersUnited States
-
Oslo University HospitalUniversity of OsloCompleted
-
Shanghai Mental Health CenterCompletedDrug Use Disorders | Addiction, DrugChina
-
Click Therapeutics, Inc.CompletedSubstance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine AddictionUnited States
-
Click Therapeutics, Inc.WithdrawnSubstance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine AddictionUnited States
-
National Institute on Drug Abuse (NIDA)CompletedDrug Addiction | Vulnerability to Substance AddictionUnited States
-
Shanghai Mental Health CenterCompleted
-
My Digital StudyCompletedSmoking Cessation | Tobacco Smoking | Tobacco Use Disorder | Substance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine AddictionUnited States
-
Medical University of South CarolinaCompletedThe Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues (addictionTBS)Alcoholism | Drug Addiction | Cocaine AddictionUnited States